NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board [Yahoo! Finance]
Beyond Air, Inc. (XAIR)
Company Research
Source: Yahoo! Finance
The company specializes in creating therapies based on small molecules that are capable of crossing the blood-brain barrier to regulate Nitric Oxide (NO) levels in the brain. Professor Roger D. Kornberg is a renowned leader in the field of eukaryotic gene transcription and a Nobel Prize winner in Chemistry in 2006. He has been appointed to NeuroNOS's Scientific Advisory Board (SAB) to provide valuable insights into the molecular mechanisms underlying neurological disorders and to drive the company's mission to develop targeted, next-generation therapies. Professor Kornberg's appointment represents a monumental step forward for NeuroNOS and underscores the company's dedication to advancing scientific excellence. His vast knowledge and pioneering work in molecular biology will significantly enhance NeuroNOS's research and development initiatives, bringing the company closer to breakthroughs that can make a real difference in the lives of those suffering from ASD and other neurologic
Show less
Read more
Impact Snapshot
Event Time:
XAIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XAIR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XAIR alerts
High impacting Beyond Air, Inc. news events
Weekly update
A roundup of the hottest topics
XAIR
News
- National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products [Yahoo! Finance]Yahoo! Finance
- Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy [Yahoo! Finance]Yahoo! Finance
- Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 TherapyGlobeNewswire
- Beyond Air Receives CE Mark in Europe for the LungFit® PH System [Yahoo! Finance]Yahoo! Finance
- Beyond Air Receives CE Mark in Europe for the LungFit® PH SystemGlobeNewswire
XAIR
Earnings
- 11/11/24 - Beat
XAIR
Sec Filings
- 12/20/24 - Form 8-K
- 12/13/24 - Form S-8
- 12/6/24 - Form 8-K
- XAIR's page on the SEC website